Subcutaneous Dosing is a drug administration method in which a therapeutic agent is delivered beneath the skin into the subcutaneous tissue, enabling sustained absorption and bioavailability while minimizing systemic variability compared to intravenous delivery.
322
Publications
16.4K
Citations
1.9K
Authors
639
Institutions
Publications per year
2017–2026
79
Publications
322
Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine
David W. Dodick, Stephen D. Silberstein, Marcelo E. Bigal et al. · JAMA · 2018 · 573 citations · Full text
1–5 of 322
Authors
1.9K
- HH
5
h-index
- ÉBÉduardo Bruera
The University of Texas MD Anderson Cancer Center, United States
5 publications · 172 citations
5
h-index
- RC
5
h-index
- DIDavid I. Bernstein
Cincinnati Children's Hospital Medical Center, United States
4 publications · 355 citations
4
h-index
- AP
4
h-index
1–5 of 1.9K
Institutions
639
Novo Nordisk (Denmark)
Copenhagen, Denmark
11 h-index
33 publications
3.2K citations
Novartis (Switzerland)
Basel, Switzerland
9 h-index
23 publications
1.3K citations
Roche (Switzerland)
Basel, Switzerland
9 h-index
26 publications
1.1K citations
University of North Carolina at Chapel Hill
Chapel Hill, United States
6 h-index
10 publications
444 citations
Stanford University
Stanford, United States
6 h-index
58 publications
4.3K citations
Triangle
Malden, United States
4 h-index
9 publications
401 citations
Janssen (United States)
Hopewell, United States
4 h-index
23 publications
1.1K citations
Research Triangle Park Foundation
Durham, United States
4 h-index
11 publications
260 citations
1–8 of 639
Venues
- PubMed
Repository · 23 publications · 570 citations
15
h-index
- Antimicrobial Agents and Chemotherapy
AAC · 7 publications · 778 citations
7
h-index
- Headache The Journal of Head and Face Pain
7 publications · 316 citations
7
h-index
- Journal of Clinical Oncology
7 publications · 939 citations
7
h-index
- Journal of Veterinary Pharmacology and Therapeutics
7 publications · 174 citations
7
h-index
1–5